Study shows Wegovy easing heart failure symptoms for patients with diabetes
Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity. Patients who took Wegovy reported less fatigue, less leg swelling, were…#novonordiskas #novo #danish #jama (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Wegovy ’s heart benefits are not just linked with weight loss, new study suggests
People with obesity-related heart failure and diabetes can get substantial heart-health benefits from weight-loss drug Wegovy, even if they don’t shed many pounds on the medication, according to new research. (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Novo ’s Wegovy Aids Heart Failure Patients With Diabetes in Study
(Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
SGLT2 Inhibitors Safe for HF in Congenital Heart Disease SGLT2 Inhibitors Safe for HF in Congenital Heart Disease
SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 5, 2024 Category: Cardiology Tags: Cardiology Source Type: news
From headaches, flatulence and now heart failure, ALL the health complications linked to vaping - and why it's NOT as safe as you might think
Calls for further action on vaping in Britain comes as yet another study suggests using vapes increases the risk of serious health complications, this time of heart failure. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2024 Category: Consumer Health News Source Type: news
SPECT/CT algorithm predicts heart failure hospitalizations
This study represents the first evidence, to our knowledge, demonstrating that integrating SPECT MPI into an AI-based risk assessment algorithm significantly improves the prediction of hospitalizations due to [heart failure],” the group wrote. The research was published March 28 in the Journal of Nuclear Medicine.Heart failure is a major cause of morbidity and mortality in the United States and worldwide, with prevalence projected to increase by almost 50% from 2012 to 2030, the authors wrote. They noted that identifying patients who are at risk for heart failure exacerbation can open opportunities for prevention strateg...
Source: AuntMinnie.com Headlines - April 3, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Artificial Intelligence Source Type: news
An AI Stethoscope ’s New Algorithm To Predict Heart Failure Gets FDA Clearance
Eko Health, which has developed digital stethoscopes that use AI to detect different heart conditions, received clearance for an algorithm that spots when hearts are pumping less than they should. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 2, 2024 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare AI /ai Editors' Pick editors-pick Premium Content premiumcontent technology alexknappblog Source Type: news
E-Cigarettes Tied to Heart Failure
(MedPage Today) -- Use of electronic nicotine products was associated with incident heart failure, a prospective study found.
People who self-reported ever having used electronic cigarettes (e-cigarettes) were 19% more likely to develop heart... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 2, 2024 Category: Cardiology Source Type: news
SGLT2i Better Than Diuretic for Early Decongestion in Acute Heart Failure?
(MedPage Today) -- Starting dapagliflozin (Farxiga) early during acute heart failure hospitalization didn't boost decongestion, although it appeared to spare loop diuretic doses and increase diuresis compared with usual care, the DICTATE-AHF trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 2, 2024 Category: Cardiology Source Type: news
Fresh health warning over vaping as shock study finds e-cigarettes may raise risk of heart failure
Dr Yakubu Bene-Alhasan from MedStar Health in Baltimore, US, said the results suggested that those who use e-cigarettes were 19 per cent more likely to develop heart failure. (Source: the Mail online | Health)
Source: the Mail online | Health - April 2, 2024 Category: Consumer Health News Source Type: news
Vaping Could Raise Your Risk for Heart Failure
TUESDAY, April 2, 2024 -- Think vaping is the " healthy " alternative to smoking? Think again: A new study finds it raises people ' s odds for heart failure. “More and more studies are linking e-cigarettes to harmful effects and finding that it might... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 2, 2024 Category: General Medicine Source Type: news
Vaping Health Risks: Study Suggests Nearly 20% Increased Threat Of Heart Disease From E-Cigarette Use
Over six million Americans experienced heart failure in 2020, and that number is estimated to increase to 8.5 million by 2030. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 2, 2024 Category: Pharmaceuticals Authors: Arianna Johnson, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Breaking breaking-news Trending Explainer Trending-Explainer topline Source Type: news
Acute high-output heart failure with pulmonary hypertension and severe liver injury caused by amlodipine poisoning: a case report - Wang C, Zhu Q, Tan D, Walline J, Wang Y.
We report a 52-year-old woman who suffered from severe shock after an overdose of amlodipine. Hemodynamic monitoring showed tha... (Source: SafetyLit)
Source: SafetyLit - March 28, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
How Hypertrophic Cardiomyopathy Progresses in Adults
Hypertrophic cardiomyopathy is the most common form of genetic heart disease worldwide. Researchers have estimated that up to 1 in 200 people have the condition, which is characterized by an abnormal thickening of the walls of the heart. This thickening can make it difficult for the heart to pump blood.
Hypertrophic cardiomyopathy can be a deadly disease, and there was a time when it was largely untreatable. But the last 20 years have witnessed a sea change in the condition’s management—a change that has led to an estimated 10-fold decrease in deaths.
[time-brightcove not-tgx=”true”]
“...
Source: TIME: Health - March 27, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance healthscienceclimate Source Type: news
Heart Failure Prevention: Early Detection Matters, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain a better understanding of the stages of heart failure and why early detection is essential for improving patient outcomes. Attendees will learn about the current guidelines for the detection and management of heart disease. The featured speakers will discuss... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 26, 2024 Category: Pharmaceuticals Tags: FVT Source Type: news
